• There are no suggestions because the search field is empty.
Author Avatar
Kirsten Van Garsse, Authorized Representative Director & Regulatory Affairs Manager
Regulatory Affairs
In Vitro Diagnostics

On October 9th, 2024, Commission Implementing Decisions (EU) 2024/2625 and (EU) 2024/2631 were published in the Official Journal of the European Union, adopting two new harmonized standards under Regulation (EU) 2017/746 (IVDR) and one under Regulation (EU) 2017/745 (MDR). 

Newly Listed Harmonized Standards | QbD Group Regulatory Update
1:12

EN ISO 13408-1:2024 Aseptic processing of health care products – Part 1: General requirements (ISO 13408-1:2023) is now a harmonised standard under both the MDR and the IVDR, whereas EN ISO 20916:2024 In vitro diagnostic medical devices – Clinical performance studies using specimens from human subjects – Good study practice (ISO 20916:2019) is now a harmonised standard under the IVDR.

Commission Implementing Decision (EU) 2024/2625 amending Implementing Decision (EU) 2021/1195

Commission Implementing Decision (EU) 2024/2631 amending Implementing Decision (EU) 2021/1182

 

What does it mean to you?


Compliance with standards ISO 13408-1:2023 or ISO 20916:2019, while not mandatory, now confers a presumption of conformity with the corresponding requirements set out in either the MDR or the IVDR.

 

 

 

Stay ahead in life sciences

Keeping up with the fast-paced life sciences industry doesn’t have to be overwhelming.

Our newsletter delivers the latest insights, industry updates, and expert content directly to your inbox, helping you stay informed and make smarter decisions.

Circles-banner-short